The National Institutes of Health (NIH) released in the Journal of the American Medical Association on Sept. 26, a new strategic plan for tuberculosis (TB) aiming to strengthen research, diagnostic tools and clinical efforts to tackle the disease, according to a NIH news release.

In 2016, Medicaid spending reached $581 billion—the highest level ever for the federal program—and covered an estimated 72 million beneficiaries. Over the next decade, spending is projected to rise 5.7 percent a year, topping $1 trillion by 2026.

BlueCross BlueShield of Tennessee has decided to expand Medicare coverage for cardiac PET, effective later this year.

As the trade war between the U.S. and China continues, the medical technology industry is bracing for heavy impact from China's $5 billion in tariffs on imported U.S. goods—including medical imaging devices and technology, according to an article published Sept. 24 by Forbes.

Pharmacy benefit managers (PBMs)—the industry middlemen that negotiate drug prices—are passing on nearly all their savings to insurance providers, according to Terry Wilcox, co-founder and executive director of advocacy organization Patients Rising. His op-ed for The Hill placed the blame of high costs squarely on insurers.

The Association of American Physicians and Surgeons (AAPS) wrote a letter to Attorney General Jeff Sessions in opposition to the $69 billion merger of CVS Health and Aetna.

Nine industry groups have joined in opposition to CMS’s proposed changes to the Medicare Shared Savings Program.

As the American population ages, the number of cases of Alzheimer’s disease and other forms of dementia is set to explode, according to the CDC.